SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001922140-24-000001
Filing Date
2024-01-31
Accepted
2024-01-31 18:39:46
Documents
1
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4771
  Complete submission text file 0001922140-24-000001.txt   6421
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address
Ma-Weaver Jacob (Reporting) CIK: 0001922140 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 24584399